CJC-1295 (No DAC) + MOTS-c Combines mitochondrial efficiency with GH-driven metabolic activity
Right now, we are limited to what we call autologous products, which include platelet-rich plasma (PRP), bone marrow aspirate concentrate, and adipose tissue, all of which are allowed by the FDA and none of which are prohibited
Ipamorelin human pharmacology data are more limited
Based on the phase 2 and phase 3 trial protocols: Weeks 1-4: 1 mg once weekly Weeks 5-8: 2 mg once weekly Weeks 9-12: 4 mg once weekly Weeks 13-16: 8 mg once weekly Weeks 17 onward: 12 mg once weekly (maximum dose) The starting dose of retatrutide is deliberately low because the triple-agonist mechanism produces more intense initial side effects than single-pathway compounds
Generalized polarization (GP) values represent membrane rigidity (higher value, red) or fluidity (lower value, blue)
Liposomal technology brilliantly solves this bioavailability crisis through sophisticated structural mimicry